Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300 |
Resumo: | Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization of infected tissue oxygenation and for its bactericidal and bacteriostatic effects.Material and Methods: The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier’s gangrene that had been treated at our center with hyperbaric oxygen therapy.Results: A total of 34 patients were treated. The vast majority of patients were males (94.1%) with a mean age of 53.7 years. Urinary tract was the most frequent source of infection and diabetes was most common comorbidity seen in patients. Mortality rate was 20.8%.Discussion: The most common observed comorbidity was diabetes, suggesting diabetes as one predisposing factor. The majority of deceased patients had diabetes, although no significant correlation between diabetes and death was found. The area of residence of patients may affect patients’ referral to these facilities.Conclusions: Although Fournier’s gangrene is a rare condition, it is nevertheless a fatal illness, namely in patients with comorbidities like diabetes. Hyperbaric oxygen therapy is recommended as an adjuvant to conventional therapy and should be considered whenever available. To further assess the role of hyperbaric oxygen therapy, in the treatment of this condition, additional studies should be carried out. |
id |
RCAP_f0869ba78cee5256e3441c231449598f |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/6300 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 CasesOxigenoterapia Hiperbárica no Tratamento da Gangrena de Fournier: RevisãoFournier GangreneHyperbaric Oxygenation.Gangrena de FournierOxigenação Hiperbárica.Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization of infected tissue oxygenation and for its bactericidal and bacteriostatic effects.Material and Methods: The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier’s gangrene that had been treated at our center with hyperbaric oxygen therapy.Results: A total of 34 patients were treated. The vast majority of patients were males (94.1%) with a mean age of 53.7 years. Urinary tract was the most frequent source of infection and diabetes was most common comorbidity seen in patients. Mortality rate was 20.8%.Discussion: The most common observed comorbidity was diabetes, suggesting diabetes as one predisposing factor. The majority of deceased patients had diabetes, although no significant correlation between diabetes and death was found. The area of residence of patients may affect patients’ referral to these facilities.Conclusions: Although Fournier’s gangrene is a rare condition, it is nevertheless a fatal illness, namely in patients with comorbidities like diabetes. Hyperbaric oxygen therapy is recommended as an adjuvant to conventional therapy and should be considered whenever available. To further assess the role of hyperbaric oxygen therapy, in the treatment of this condition, additional studies should be carried out.Introdução: A gangrena de Fournier é uma infecção necrotizante grave, que pode levar à morte se não for tratada rapidamente. O tratamento baseia-se na combinação do desbridamento cirúrgico, antibioterapia e terapêutica de suporte. A oxigenoterapia hiperbárica surge como adjuvante quer na optimização da oxigenação dos tecidos infetados, quer através da ação bactericida e bacteriostática.Material e Métodos: Foi feita uma revisão dos processos clínicos dos doentes com gangrena de Fournier referenciados ao Centro de Medicina Subaquática e Hiperbárica da Marinha para realizar oxigenoterapia hiperbárica num período de 25 anos.Resultados: Foram tratados 34 doentes. A maioria dos doentes era do género masculino (94,1%) com idade média de 53,7 anos. A diabetes foi a comorbilidade mais frequentemente associada. O foco de infeção mais frequente foi o trato urinário. A taxa de mortalidade foi de 20,8%.Discussão: A diabetes é a comorbilidade mais frequente, sugerindo a diabetes como factor predisponente. A maioria dos doentes falecidos tinham diabetes, todavia não se conseguiu estabelecer correlação entre diabetes e morte. A área de residência dos doentes parece limitar a referenciação ao centro.Conclusões: A gangrena de Fournier, apesar de rara, é uma doença potencialmente fatal, nomeadamente em doentes com comorbilidades como a diabetes. A oxigenoterapia hiperbárica está recomendada como adjuvante à terapêutica convencional e, quando este recurso está disponível, deve ser considerado. São necessários mais estudos para melhor aferir o papel da oxigenoterapia hiperbárica no tratamento desta entidade.Ordem dos Médicos2015-09-17info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfimage/tiffimage/tiffimage/tiffapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300oai:ojs.www.actamedicaportuguesa.com:article/6300Acta Médica Portuguesa; Vol. 28 No. 5 (2015): September-October; 619-623Acta Médica Portuguesa; Vol. 28 N.º 5 (2015): Setembro-Outubro; 619-6231646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/4495https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7791https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7792https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7793https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7859Rosa, IsabelGuerreiro, Franciscoinfo:eu-repo/semantics/openAccess2022-12-20T11:04:49Zoai:ojs.www.actamedicaportuguesa.com:article/6300Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:17.420667Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases Oxigenoterapia Hiperbárica no Tratamento da Gangrena de Fournier: Revisão |
title |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
spellingShingle |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases Rosa, Isabel Fournier Gangrene Hyperbaric Oxygenation. Gangrena de Fournier Oxigenação Hiperbárica. |
title_short |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
title_full |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
title_fullStr |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
title_full_unstemmed |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
title_sort |
Hyperbaric Oxygen Therapy for the Treatment of Fournier’s Gangrene: A Review of 34 Cases |
author |
Rosa, Isabel |
author_facet |
Rosa, Isabel Guerreiro, Francisco |
author_role |
author |
author2 |
Guerreiro, Francisco |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Rosa, Isabel Guerreiro, Francisco |
dc.subject.por.fl_str_mv |
Fournier Gangrene Hyperbaric Oxygenation. Gangrena de Fournier Oxigenação Hiperbárica. |
topic |
Fournier Gangrene Hyperbaric Oxygenation. Gangrena de Fournier Oxigenação Hiperbárica. |
description |
Introduction: Fournier’s gangrene is a serious necrotizing infection that can be fatal if not promptly attended. Treatment for this condition consists of a combination of surgical debridement, antibiotherapy and supportive care. Hyperbaric oxygen therapy is used as an adjuvant for the optimization of infected tissue oxygenation and for its bactericidal and bacteriostatic effects.Material and Methods: The data presented in this study encompass a period of 25 years of clinical records of patients with Fournier’s gangrene that had been treated at our center with hyperbaric oxygen therapy.Results: A total of 34 patients were treated. The vast majority of patients were males (94.1%) with a mean age of 53.7 years. Urinary tract was the most frequent source of infection and diabetes was most common comorbidity seen in patients. Mortality rate was 20.8%.Discussion: The most common observed comorbidity was diabetes, suggesting diabetes as one predisposing factor. The majority of deceased patients had diabetes, although no significant correlation between diabetes and death was found. The area of residence of patients may affect patients’ referral to these facilities.Conclusions: Although Fournier’s gangrene is a rare condition, it is nevertheless a fatal illness, namely in patients with comorbidities like diabetes. Hyperbaric oxygen therapy is recommended as an adjuvant to conventional therapy and should be considered whenever available. To further assess the role of hyperbaric oxygen therapy, in the treatment of this condition, additional studies should be carried out. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-09-17 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300 oai:ojs.www.actamedicaportuguesa.com:article/6300 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/6300 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/4495 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7791 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7792 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7793 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/6300/7859 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf image/tiff image/tiff image/tiff application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 28 No. 5 (2015): September-October; 619-623 Acta Médica Portuguesa; Vol. 28 N.º 5 (2015): Setembro-Outubro; 619-623 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817554011531771904 |